Search Results - "ter Hofstede, H J"

  • Showing 1 - 16 results of 16
Refine Results
  1. 1
  2. 2

    Adverse effects of reverse transcriptase inhibitors : mitochondrial toxicity as common pathway by BRINKMAN, K, TER HOFSTEDE, H. J. M, BURGER, D. M, SMEITINK, J. A. M, KOOPMANS, P. P

    Published in AIDS (London) (01-10-1998)
    “…After zidovudine (ZDV), a 3'-azido analogue of thymidine, was found to be an effective antiretroviral drug against HIV, other nucleoside analogues inhibiting…”
    Get full text
    Journal Article
  3. 3

    Carbamazepine--indinavir interaction causes antiretroviral therapy failure by Hugen, PW, Burger, DM, Brinkman, K, ter Hofstede, HJ, Schuurman, R, Koopmans, PP, Hekster, YA

    Published in The Annals of pharmacotherapy (01-04-2000)
    “…OBJECTIVE: To report a case of antiretroviral therapy failure caused by an interaction between carbamazepine and indinavir. CASE SUMMARY: A 48-year-old…”
    Get full text
    Journal Article
  4. 4

    Development of an indinavir oral liquid for children by Hugen, PW, Burger, DM, ter Hofstede, HJ, Koopmans, PP, Hekster, YA

    Published in American journal of health-system pharmacy (15-07-2000)
    “…An indinavir oral liquid was developed and studied. Several oral liquids containing indinavir were prepared and taste tested in eight healthy volunteers…”
    Get full text
    Journal Article
  5. 5

    Clinical features and risk factors of lactic acidosis following long-term antiretroviral therapy: 4 fatal cases by ter Hofstede, H J, de Marie, S, Foudraine, N A, Danner, S A, Brinkman, K

    Published in International journal of STD & AIDS (01-09-2000)
    “…Our objective was to describe clinical features and predisposing factors attributed to lactic acidosis in 4 HIV-infected patients on long-term nucleoside…”
    Get more information
    Journal Article
  6. 6
  7. 7

    Saliva as a specimen for monitoring compliance but not for predicting plasma concentrations in patients with HIV treated with indinavir by HUGEN, P. W. H, BURGER, D. M, DE GRAAFF, M, TER HOFSTEDE, H. J. M, HOETELMANS, R. M. W, BRINKMAN, K, MEENHORST, P. L, MULDER, J. W, KOOPMANS, P. P, HEKSTER, Y. A

    Published in Therapeutic drug monitoring (01-08-2000)
    “…The presence of the HIV-protease inhibitor indinavir in saliva was analyzed to investigate whether salivary indinavir concentrations are applicable to monitor…”
    Get full text
    Journal Article
  8. 8
  9. 9

    Stavudine plasma concentrations and lipoatrophy by ter Hofstede, Hadewych J. M., Koopmans, Peter P., Burger, David M.

    Published in Journal of antimicrobial chemotherapy (01-04-2008)
    “…Objectives The objective of this study was to determine the correlation between plasma stavudine concentrations and lipoatrophy (LA), one of the major adverse…”
    Get full text
    Journal Article
  10. 10

    Therapy of HIV infection: how early and how intensive? by ter Hofstede, H J, Telgt, D S, Koopmans, P P

    Published in Nederlands tijdschrift voor geneeskunde (03-02-2001)
    “…Three men aged 53, 25 and 34 years and 2 women aged 39 and 34 years with HIV infection had different courses with and without highly active antiretroviral…”
    Get more information
    Journal Article
  11. 11
  12. 12
  13. 13

    Dose-Finding Study of a Once-Daily Indinavir/Ritonavir Regimen by Hugen, Patricia W. H, Burger, David M, ter Hofstede, Hadewych J. M, Koopmans, Peter P, Stek, Michael, Hekster, Yechiel A, Reiss, Peter, Lange, Joep M.A

    “…In antiretroviral therapy, to improve compliance the need is increasing to develop regimens that combine potency and safety with convenient dosing. The…”
    Get full text
    Journal Article
  14. 14

    Serum l-lactate and pyruvate in HIV-infected patients with and without presumed NRTI-related adverse events compared to healthy volunteers by ter Hofstede, Hadewych J.M., Willems, Hans L., Koopmans, Peter P.

    Published in Journal of clinical virology (2004)
    “…Background: Nucleoside reverse transcriptase inhibitors (NRTIs) used in antiretroviral therapy may cause mitochondrial toxicity. Mitochondrial dysfunction…”
    Get full text
    Journal Article
  15. 15

    Hepatic steatosis during treatment with zidovudine and lamivudine in an HIV-positive patient by ter Hofstede, H J, Koopmans, P P, van Haelst, U J

    Published in Nederlands tijdschrift voor geneeskunde (21-02-1998)
    “…A 33-year-old HIV-infected man was given antiretroviral therapy with zidovudine and lamivudine. After ten months' treatment the patient had elevated hepatic…”
    Get more information
    Journal Article
  16. 16